Enliven Therapeutics, Inc.

ELVNReported to SECin USCIK 0001672619Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 41. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 41
Form 4 lines at Enliven Therapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Hohl BenjaminCHIEF FINANCIAL OFFICEROption exercisenothing paid3,982 sharesSep 21, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERnothing paidExercise · Sep 21Option exercise3,982Sep 21, 2026
Hohl BenjaminCHIEF FINANCIAL OFFICEROpen-market sell$14,881289 sharesSep 21, 2026Hohl BenjaminCHIEF FINANCIAL OFFICER$14,881Sell · Sep 21Open-market sell289Sep 21, 2026
Hohl BenjaminCHIEF FINANCIAL OFFICEROpen-market sell$111,2702,194 sharesSep 21, 2026Hohl BenjaminCHIEF FINANCIAL OFFICER$111,270Sell · Sep 21Open-market sell2,194Sep 21, 2026
Hohl BenjaminCHIEF FINANCIAL OFFICEROpen-market sell$176,8513,535 sharesSep 21, 2026Hohl BenjaminCHIEF FINANCIAL OFFICER$176,851Sell · Sep 21Open-market sell3,535Sep 21, 2026
Hohl BenjaminCHIEF FINANCIAL OFFICEROption exercise$59,1333,982 sharesSep 21, 2026Hohl BenjaminCHIEF FINANCIAL OFFICER$59,133Exercise · Sep 21Option exercise3,982Sep 21, 2026